PROJECTS
KF VENTURES
FEATURED INVESTMENTS
Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models.
Acquired by Roche, Oct 2023
Tegmine combines mass spectrometry, machine learning, and biology to develop novel targets and highly selective ADCs for oncology.
Waypoint bio
Waypoint uses spatial biology and pooled screening to develop optimized cell therapies.
topos Bio
Mol Dyn meets LLMs.
KF VENTURES
FEATURED INVESTMENTS
Herophilus is a neurotherapeutics discovery company based on next-generation scaled complex in vitro models.
Acquired by Roche, Oct 2023
Onc.AI is a digital health company on a mission to radically improve oncology decision making.
Tegmine combines mass spectrometry, machine learning, and biology to develop highly selective antibody drug targets for oncology.
DotLab is a women’s healthcare technology company developing a circulating micro RNA blood test to diagnose active endometriosis.
Stealth co.
Mol Dyn meets LLMs.